BrainsWay Ltd. (BRSYF)
BRSYF Stock Price Chart
Explore BrainsWay Ltd. interactive price chart. Choose custom timeframes to analyze BRSYF price movements and trends.
BRSYF Company Profile
Discover essential business fundamentals and corporate details for BrainsWay Ltd. (BRSYF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
21 Apr 2011
Employees
120.00
Website
https://www.brainsway.comCEO
Hadar Levy
Description
Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.
BRSYF Financial Timeline
Browse a chronological timeline of BrainsWay Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 May 2026
Upcoming earnings on 9 Mar 2026
Upcoming earnings on 11 Nov 2025
Revenue estimate is $13.06M.
Earnings released on 13 Aug 2025
EPS came in at $0.05 , while revenue for the quarter reached $12.63M , missing expectations by -1.86%.
Earnings released on 13 May 2025
EPS came in at $0.02 falling short of the estimated $0.03 by -33.33%, while revenue for the quarter reached $11.54M , missing expectations by -5.18%.
Earnings released on 11 Mar 2025
EPS came in at $0.04 surpassing the estimated $0.02 by +100.00%, while revenue for the quarter reached $11.41M , missing expectations by -0.88%.
Earnings released on 12 Nov 2024
EPS came in at $0.02 surpassing the estimated $0.01 by +185.71%, while revenue for the quarter reached $10.50M , missing expectations by -3.27%.
Earnings released on 6 Aug 2024
EPS came in at $0.02 surpassing the estimated $0.01 by +100.00%, while revenue for the quarter reached $9.86M , missing expectations by -1.05%.
Earnings released on 8 May 2024
EPS came in at $0.00 surpassing the estimated $0.00 by +100.00%, while revenue for the quarter reached $9.01M , beating expectations by +2.43%.
Earnings released on 6 Mar 2024
EPS came in at $0.00 surpassing the estimated $0.00 by +100.00%, while revenue for the quarter reached $9.50M .
Earnings released on 15 Nov 2023
EPS came in at -$0.01 falling short of the estimated -$0.01 by -75.13%, while revenue for the quarter reached $8.30M .
Earnings released on 9 Aug 2023
EPS came in at -$0.05 surpassing the estimated -$0.08 by +37.50%, while revenue for the quarter reached $7.83M .
Earnings released on 17 May 2023
EPS came in at -$0.07 surpassing the estimated -$0.09 by +22.22%, while revenue for the quarter reached $6.63M .
Earnings released on 15 Mar 2023
EPS came in at -$0.12 matching the estimated -$0.12, while revenue for the quarter reached $6.03M .
Earnings released on 16 Nov 2022
EPS came in at -$0.15 falling short of the estimated -$0.06 by -150.00%, while revenue for the quarter reached $5.17M .
Earnings released on 10 Aug 2022
EPS came in at -$0.07 matching the estimated -$0.07, while revenue for the quarter reached $8.01M .
Earnings released on 11 May 2022
EPS came in at -$0.06 surpassing the estimated -$0.09 by +33.33%, while revenue for the quarter reached $7.97M , beating expectations by +17.21%.
Earnings released on 9 Mar 2022
EPS came in at -$0.04 surpassing the estimated -$0.05 by +20.00%, while revenue for the quarter reached $8.47M , beating expectations by +24.56%.
Earnings released on 17 Nov 2021
EPS came in at -$0.10 falling short of the estimated -$0.06 by -66.67%, while revenue for the quarter reached $8.06M , beating expectations by +18.54%.
Earnings released on 11 Aug 2021
EPS came in at -$0.06 matching the estimated -$0.06, while revenue for the quarter reached $7.01M .
Earnings released on 20 May 2021
EPS came in at -$0.11 falling short of the estimated -$0.08 by -37.50%, while revenue for the quarter reached $6.12M .
Earnings released on 25 Mar 2021
EPS came in at -$0.02 surpassing the estimated -$0.05 by +60.00%, while revenue for the quarter reached $7.07M .
Earnings released on 18 Nov 2020
EPS came in at -$0.04 matching the estimated -$0.04, while revenue for the quarter reached $6.01M .
BRSYF Stock Performance
Access detailed BRSYF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.